3 Stocks Estimated To Be Trading At A Discount Of Up To 36.2%

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying stocks that are trading at a discount can offer potential opportunities for investors seeking value in a growing market.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Roku (ROKU)	$94.62	$187.39	49.5%
iRhythm Holdings (IRTC)	$118.02	$230.66	48.8%
Hasbro (HAS)	$93.60	$185.05	49.4%
Ellington Financial (EFC)	$11.85	$23.19	48.9%
Dime Community Bancshares (DCOM)	$33.82	$66.58	49.2%
CuriosityStream (CURI)	$2.96	$5.73	48.4%
Crexendo (CXDO)	$6.17	$11.93	48.3%
Bar Harbor Bankshares (BHB)	$32.45	$63.66	49%
Andersen Group (ANDG)	$27.20	$53.13	48.8%
Allot (ALLT)	$6.66	$13.22	49.6%

Click here to see the full list of 156 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

MercadoLibre (MELI)

Overview: MercadoLibre, Inc. operates online commerce platforms in Brazil, Mexico, Argentina, and internationally with a market cap of approximately $82.09 billion.

Operations: The company generates revenue of $28.89 billion from its Internet Software & Services segment.

Estimated Discount To Fair Value: 24.1%

MercadoLibre is trading at 24.1% below its estimated fair value and significantly undervalued based on discounted cash flow, with a stock price below the future cash flow estimate of US$2,277.18. Despite high debt levels, earnings grew by 4.5% last year and are expected to grow significantly over the next three years, outpacing the US market average. Recent expansion plans include a US$3.4 billion investment in Argentina for logistics and fintech growth in 2026.

• Our growth report here indicates MercadoLibre may be poised for an improving outlook.
• Click to explore a detailed breakdown of our findings in MercadoLibre's balance sheet health report.

Palo Alto Networks (PANW)

Overview: Palo Alto Networks, Inc. offers cybersecurity solutions across various global regions and has a market cap of approximately $125.18 billion.

Operations: The company's revenue primarily comes from its Security Software & Services segment, which generated $9.89 billion.

Estimated Discount To Fair Value: 12.6%

Palo Alto Networks is trading at 12.6% below its fair value estimate and slightly undervalued based on discounted cash flow, with a stock price of US$160.32 compared to the future cash flow value estimate of US$183.43. Despite recent shareholder dilution, earnings have grown significantly over the past five years and are projected to continue growing faster than the broader US market, driven by strategic product launches like Prisma AIRS 3.0 and expanded buyback plans totaling $5.11 billion.

• Our earnings growth report unveils the potential for significant increases in Palo Alto Networks' future results.
• Click here to discover the nuances of Palo Alto Networks with our detailed financial health report.

Eli Lilly (LLY)

Overview: Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products globally with a market cap of $793.37 billion.

Operations: The company generates revenue of $65.18 billion from its pharmaceutical products across various regions including the United States, Europe, China, and Japan.

Estimated Discount To Fair Value: 36.2%

Eli Lilly is trading at 36.2% below its estimated fair value, with a stock price of US$919.77 compared to the future cash flow value estimate of US$1441.72, suggesting it may be undervalued based on cash flows. Recent clinical trials, such as the TOGETHER-PsA study, show promising results for combined therapies addressing psoriatic arthritis and obesity, potentially enhancing revenue streams. Despite high debt levels, earnings have grown significantly over the past year and are forecasted to grow faster than the broader US market.

• Upon reviewing our latest growth report, Eli Lilly's projected financial performance appears quite optimistic.
• Dive into the specifics of Eli Lilly here with our thorough financial health report.

Taking Advantage

• Explore the 156 names from our Undervalued US Stocks Based On Cash Flows screener here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com